540145 — Valiant Organics Balance Sheet
0.000.00%
- IN₹9.52bn
- IN₹11.41bn
- IN₹7.23bn
- 55
- 37
- 51
- 46
Annual balance sheet for Valiant Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
R2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 174 | 350 | 503 | 493 | 71 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,584 | 1,843 | 3,475 | 2,836 | 2,863 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2,240 | 3,028 | 5,195 | 4,710 | 4,127 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 4,027 | 5,432 | 6,427 | 7,286 | 7,164 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 6,691 | 8,759 | 11,847 | 12,392 | 12,480 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,692 | 2,708 | 4,019 | 3,927 | 4,132 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 2,815 | 3,736 | 5,716 | 5,500 | 5,187 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
ESOP Debt Guarantee | |||||
Other Equity | |||||
Total Equity | 3,876 | 5,023 | 6,131 | 6,892 | 7,293 |
Total Liabilities & Shareholders' Equity | 6,691 | 8,759 | 11,847 | 12,392 | 12,480 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |